Market Overview:
The global topical corticosteroids market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of skin diseases, rising awareness about available treatment options, and growing demand for better-quality products. The global topical corticosteroids market is segmented on the basis of type into class I, class II, class III, class IV, class V, class VI and VII. Class I is further sub-segmented into super-potent steroids and potent steroids while Class VII is further sub-segmented into very low potency steroids. On the basis of application, the global topical corticosteroids market is segmented into hospitals & clinics (dermatology), pharmacies and others (including research institutes & contract manufacturing organizations). Geographically, the global topical corticosteroids market is segmented into North America (U.S., Canada), Latin America (Brazil Mexico), Europe (Germany France U.K.), Asia Pacific (China Japan India) and Middle East & Africa(South Africa Saudi Arabia).
Product Definition:
Topical corticosteroids are a class of medications that are applied to the skin. They are used to treat inflammation and various skin conditions, such as eczema and psoriasis.
Class I:
Topical corticosteroids are the drugs that are used to reduce inflammation and itching by suppressing the production of cytokines. Cytokines are proteins that act as messengers between cells in the immune system.
Class II:
Topical corticosteroids are used for the treatment of inflammatory skin conditions such as atopic dermatitis. They are also used in the treatment of psoriasis and sebostasis. The mechanism of action involves inhibition or reduction in cytokines production by immune cells, which results in reduced inflammation. Topical corticosteroids may be administered with a moisturizer (topical lotion) or without (topical cream, ointment).
Application Insights:
The others segment dominated the market and accounted for more than 54.0% share of the global revenue in 2017. The other application includes ophthalmic, ears, nose and Throat (ENT) clinics, pharmacies and hospitals. Hospitals were the largest application segment accounting for a significant share of topicals in 2017 owing to their high usage rates compared to other locations such as dermatology clinics or pharmacies.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing prevalence of skin disorders are some factors responsible for its growth. In addition, the availability of products with improved efficacy and safety is expected to drive their adoption over the forecast period. For instance, in May 2018 BIM23S7 received FDA approval for treating eczema in adults as well as children above 6 years of age which was earlier approved only for pediatric patients aged 2 years and below.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast period owing to rising disposable income levels coupled with growing healthcare spending by governments & private entities along with an increase in awareness about topical corticosteroids use among patients suffering from atopic dermatitis/eczema or psoriasis vulgaris/psoriatic arthritis etc.
Growth Factors:
- Increasing incidence of skin diseases: The global topical corticosteroids market is expected to grow at a CAGR of 5.5% from 2016 to 2021, owing to the increasing incidence of skin diseases such as psoriasis, eczema, and dermatitis.
- Rising awareness about the benefits of topical corticosteroids: There is a growing awareness among consumers about the benefits of using topical corticosteroids for various skin conditions. This is likely to drive the growth of the global market in the coming years.
- Growing demand for combination therapies: Topical corticosteroids are increasingly being used in combination with other drugs and therapies for better results. This is expected to boost demand for these products in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Topical Corticosteroids Market Research Report
By Type
Class I, Class II, Class III, Class IV, Class V, Class VI, Class VII
By Application
Hospitals, Dermatology Clinics, Pharmacies, Others
By Companies
AstraZeneca plc, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Actimis Pharmaceuticals, Bausch Health, Almirall, S.A, Zylera Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
210
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Topical Corticosteroids Market Report Segments:
The global Topical Corticosteroids market is segmented on the basis of:
Types
Class I, Class II, Class III, Class IV, Class V, Class VI, Class VII
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Dermatology Clinics, Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca plc
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Pfizer Inc.
- Sandoz AG (Novartis AG)
- Sanofi S.A.
- Actimis Pharmaceuticals
- Bausch Health
- Almirall, S.A
- Zylera Pharmaceuticals
Highlights of The Topical Corticosteroids Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Class I
- Class II
- Class III
- Class IV
- Class V
- Class VI
- Class VII
- By Application:
- Hospitals
- Dermatology Clinics
- Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Topical Corticosteroids Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Topical corticosteroids are medications that are applied to the skin. They work by reducing inflammation and swelling.
Some of the major companies in the topical corticosteroids market are AstraZeneca plc, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Actimis Pharmaceuticals, Bausch Health, Almirall, S.A, Zylera Pharmaceuticals.
The topical corticosteroids market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Topical Corticosteroids Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Topical Corticosteroids Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Topical Corticosteroids Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Topical Corticosteroids Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Topical Corticosteroids Market Size & Forecast, 2018-2028
4.5.1 Topical Corticosteroids Market Size and Y-o-Y Growth
4.5.2 Topical Corticosteroids Market Absolute $ Opportunity
Chapter 5 Global Topical Corticosteroids Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Topical Corticosteroids Market Size Forecast by Type
5.2.1 Class I
5.2.2 Class II
5.2.3 Class III
5.2.4 Class IV
5.2.5 Class V
5.2.6 Class VI
5.2.7 Class VII
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Topical Corticosteroids Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Topical Corticosteroids Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Dermatology Clinics
6.2.3 Pharmacies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Topical Corticosteroids Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Topical Corticosteroids Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Topical Corticosteroids Analysis and Forecast
9.1 Introduction
9.2 North America Topical Corticosteroids Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Topical Corticosteroids Market Size Forecast by Type
9.6.1 Class I
9.6.2 Class II
9.6.3 Class III
9.6.4 Class IV
9.6.5 Class V
9.6.6 Class VI
9.6.7 Class VII
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Topical Corticosteroids Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Dermatology Clinics
9.10.3 Pharmacies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Topical Corticosteroids Analysis and Forecast
10.1 Introduction
10.2 Europe Topical Corticosteroids Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Topical Corticosteroids Market Size Forecast by Type
10.6.1 Class I
10.6.2 Class II
10.6.3 Class III
10.6.4 Class IV
10.6.5 Class V
10.6.6 Class VI
10.6.7 Class VII
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Topical Corticosteroids Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Dermatology Clinics
10.10.3 Pharmacies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Topical Corticosteroids Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Topical Corticosteroids Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Topical Corticosteroids Market Size Forecast by Type
11.6.1 Class I
11.6.2 Class II
11.6.3 Class III
11.6.4 Class IV
11.6.5 Class V
11.6.6 Class VI
11.6.7 Class VII
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Topical Corticosteroids Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Dermatology Clinics
11.10.3 Pharmacies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Topical Corticosteroids Analysis and Forecast
12.1 Introduction
12.2 Latin America Topical Corticosteroids Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Topical Corticosteroids Market Size Forecast by Type
12.6.1 Class I
12.6.2 Class II
12.6.3 Class III
12.6.4 Class IV
12.6.5 Class V
12.6.6 Class VI
12.6.7 Class VII
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Topical Corticosteroids Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Dermatology Clinics
12.10.3 Pharmacies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Topical Corticosteroids Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Topical Corticosteroids Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Topical Corticosteroids Market Size Forecast by Type
13.6.1 Class I
13.6.2 Class II
13.6.3 Class III
13.6.4 Class IV
13.6.5 Class V
13.6.6 Class VI
13.6.7 Class VII
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Topical Corticosteroids Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Dermatology Clinics
13.10.3 Pharmacies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Topical Corticosteroids Market: Competitive Dashboard
14.2 Global Topical Corticosteroids Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca plc
14.3.2 GlaxoSmithKline plc
14.3.3 Merck & Co., Inc.
14.3.4 Pfizer Inc.
14.3.5 Sandoz AG (Novartis AG)
14.3.6 Sanofi S.A.
14.3.7 Actimis Pharmaceuticals
14.3.8 Bausch Health
14.3.9 Almirall, S.A
14.3.10 Zylera Pharmaceuticals
